These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23477159)

  • 21. Usage and adverse effects of Chinese herbal medicines.
    Chan TY; Critchley JA
    Hum Exp Toxicol; 1996 Jan; 15(1):5-12. PubMed ID: 8845209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting drug-herbal interaction using a spontaneous reporting system database: an example with benzylpenicillin and qingkailing injection.
    Li H; Deng J; Yue Z; Zhang Y; Sun H
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1139-45. PubMed ID: 26159784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Academic discussion of adverse reaction of clinical trials of new traditional Chinese medicines and relevant influencing factors].
    Wang WP; Yu M; Wang L; Jiang XR; Li XB; Wang HW; Cao Y; Liu K; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(2):346-50. PubMed ID: 26080571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Retrospective Analysis on 1330 Adverse Event Reports of Qingkailing in China: Further Perception of Its Risks and Rational Use.
    Wu BL; He WX; Ke M; Shang-Guan XF; He GF; Huang R
    Curr Med Sci; 2018 Dec; 38(6):1103-1108. PubMed ID: 30536076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence use and harmful potential of some Chinese herbal medicines in babies and children.
    Chan TY
    Vet Hum Toxicol; 1994 Jun; 36(3):238-40. PubMed ID: 8066974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National adverse drug reaction surveillance. 1986.
    Faich GA; Dreis M; Tomita D
    Arch Intern Med; 1988 Apr; 148(4):785-7. PubMed ID: 3355297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
    Xie Y; Tian F
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of clinical safety for Shenmai injection based on literature].
    Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2779-81. PubMed ID: 23285932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of suspected adverse reactions to natural health products in Italy.
    Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Security revaluation study based on nested case-control method of Danhong injection].
    Li CX; Tang JF; Meng F; Li XL
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2735-8. PubMed ID: 23285922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication with caution: Analysis of adverse reactions caused by a combination of Chinese medicine and warfarin sodium tablets.
    Zhuang W; Sun G; Lin X; Chen B; Wu L; Jiang D; Xi S
    J Ethnopharmacol; 2020 May; 254():112586. PubMed ID: 32109544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China.
    Huang R; Cai Y; Yang L; Shangguan X; Ghose B; Tang S
    Sci Rep; 2021 Apr; 11(1):8875. PubMed ID: 33893351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data].
    Wang ZF; Xiang YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3008-12. PubMed ID: 24471321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Data-mining characteristics of adverse drug reactions and pharmacovi-gilance of Chinese patent drugs including Aconitum herbs].
    Zhang XM; Li F; Zhang B; Chen XF; Piao JZ
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):216-221. PubMed ID: 29552835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [To strengthen the monitoring and research on clinical adverse drug reaction induced by Chinese medicines].
    Chen K
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1091. PubMed ID: 11766603
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serious cutaneous adverse reactions to traditional Chinese medicines.
    Lim YL; Thirumoorthy T
    Singapore Med J; 2005 Dec; 46(12):714-7. PubMed ID: 16308646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].
    Zhang L; Yang XH; Cao LY; Ji S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):581-4. PubMed ID: 16089130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database.
    Li X; Thai S; Lu W; Sun S; Tang H; Zhai S; Wang T
    Int J Clin Pharm; 2018 Aug; 40(4):921-927. PubMed ID: 30051226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.